Mitoxantrone Unknown Status Phase 4 Trials for Acute Promyelocytic Leukemia (APL) Prevention

IndicationsStatusPurposePhase
Unknown StatusPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00180128AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia